Steward Partners Investment Advisory
ARCT icon

Steward Partners Investment Advisory’s Arcturus Therapeutics ARCT Stock Holding History

Steward Partners Investment Advisory’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$706 Buy
105
+3
+3% +$24 ﹤0.01% 4426
2026
Q1 		$787 Hold
102
– – ﹤0.01% 4218
2025
Q4 		$625 Hold
102
– – ﹤0.01% 4132
2025
Q3 		$1.88K Buy
+102
New +$1.64K ﹤0.01% 3935
2021
Q2 		– Sell
-200
Closed -$8.26K – 7088
2021
Q1 		$8.26K Buy
+200
New +$11.9K ﹤0.01% 2857

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Steward Partners Investment Advisory's ARCT Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Arcturus Therapeutics (ARCT) stake by 2.9% in Q2 2026, buying an estimated $24 and bringing the position to 105 shares worth $706. The position accounts for ﹤0.01% of the portfolio, ranked #4426.

Steward Partners Investment Advisory first reported a position in ARCT in Q1 2021 and has held it in 5 quarters since. The position peaked at $8.26K in Q1 2021. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Steward Partners Investment Advisory held 105 shares of Arcturus Therapeutics worth $706 as of Q2 2026.
  • Steward Partners Investment Advisory bought 3 Arcturus Therapeutics shares in Q2 2026, an estimated $24.
  • Arcturus Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4426 holding.
  • Steward Partners Investment Advisory first reported a position in Arcturus Therapeutics in Q1 2021 and has held it in 5 quarters since.
  • Steward Partners Investment Advisory's Arcturus Therapeutics position peaked at $8.26K in Q1 2021.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.